Endothelial Progenitor Cells and Kidney Diseases

Kidney & Blood Pressure Research
Abdullah Ozkok, Alaattin Yildiz

Abstract

Endothelial progenitor cells (EPC) are bone marrow derived or tissue-resident cells that play major roles in the maintenance of vascular integrity and repair of endothelial damage. Although EPCs may be capable of directly engrafting and regenerating the endothelium, the most important effects of EPCs seem to be depended on paracrine effects. In recent studies, specific microvesicles and mRNAs have been found to mediate the pro-angiogenic and regenerative effects of EPCs on endothelium. EPC counts have important prognostic implications in cardiovascular diseases (CVD). Uremia and inflammation are associated with lower EPC counts which probably contribute to increased CVD risks in patients with chronic kidney disease. Beneficial effects of the EPC therapies have been shown in studies performed on different models of CVD and kidney diseases such as acute and chronic kidney diseases and glomerulonephritis. However, lack of a clear definition and specific marker of EPCs is the most important problem causing difficulties in interpretation of the results of the studies investigating EPCs.

Citations

Jun 12, 2019·International Journal of Molecular Sciences·Cinzia RotaBarbara Imberti
Jan 2, 2019·International Journal of Molecular Sciences·Ming-Tsun Tsai, Der-Cherng Tarng
Aug 6, 2020·Life·Jinwen LinJianghua Chen
Sep 2, 2020·Stem Cell Research & Therapy·Xiaoyan ChenXiao Su
Dec 3, 2020·Frontiers in Oncology·Long DaoShulin Li
Aug 10, 2021·World Journal of Stem Cells·Chee-Yin Wong

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiovascular Inflammation

Inflammation plays a significant role in the development of cardiovascular diseases, an understanding of these endogenous processes is critical for evaluating the risks and potential treatment strategies. Discover the latest research on cardiovascular inflammation here.

Biomarkers for Cardiovascular Risk Assessment

Sensitive and accurate biomarkers used in cardiovascular risk prediction can potentially be used to manage the risk of cardiovascular disease. Discover the latest research on Biomarkers for Cardiovascular Risk Assessment here. Discover the latest research on Biomarkers for Cardiovascular Risk Assessment here.